Active, Not Recruiting
Long-Term Study That Measures the Safety and Efficacy of BMS-986165 in Participants With Psoriasis. - IM011-075
Oppdatert:
26 september, 2023
|
ClinicalTrials.gov
Fase
Kjønn
Aldersgruppe
Active, Not Recruiting
Inclusion Criteria: - Completion of the protocol-required treatment period in an applicable study of BMS-986165 in moderate-to-severe psoriasis - Women must not be pregnant, lactating, or breastfeeding Exclusion Criteria: - Any disease or medical condition that the investigator feels that would make the patient unsuitable for this study. - To be eligible for the study, a participant must not have active signs or symptoms of tuberculosis (TB) as judged by the investigator.
Vi anbefaler at du kontakter BMS for å rapportere bivirkninger.
Bivirkninger (uønskede hendelser) og andre rapporterbare hendelser er definert her
For å rapportere bivirkninger (uønskede hendelser) eller reklamere på et legemiddel: Medisinsk informasjon
MLTNO2000046